Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?

Medical Mycology
Sergio Álvarez-PérezJosé L Blanco

Abstract

A total of 216 colonies of Malassezia pachydermatis from 28 cases of fungal otitis or dermatitis in pets were genotyped by M13 fingerprinting and tested for antifungal susceptibility. A huge genetic diversity was found (157 M13 types in total), with all animals having a polyclonal pattern of infection (5.4 ± 1.5 genotypes/sample). Furthermore, analysis of molecular variance (AMOVA) revealed that most genetic diversity (44%) was found at the within sample level. In contrast, variability in antifungal susceptibility among isolates from the same sample was less important, with different M13 types displaying in most cases identical or very similar MIC results. Most isolates displayed high in vitro susceptibility to amphotericin B, terbinafine and all azoles tested except fluconazole, for which MIC values were always ≥4 μg/ml and a 26.9% of isolates displayed values ≥32 μg/ml. We conclude that although characterization of multiple yeast isolates results in a considerable increase in laboratory workload and expenses, it may help to get a better understanding of the epidemiology of M. pachydermatis in a given patient population.

References

Jun 8, 2000·International Journal of Systematic and Evolutionary Microbiology·J W FellA Statzell-Tallman
Apr 6, 2004·The Veterinary Clinics of North America. Small Animal Practice·Edmund J Rosser
Feb 12, 2005·Emerging Infectious Diseases·Daniel O Morris
Jun 1, 2005·Veterinary Microbiology·G CastelláF J Cabañes
Feb 27, 2007·Molecular and Cellular Probes·Claudia CafarchiaDomenico Otranto
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Jun 21, 2008·Veterinary Immunology and Immunopathology·Jose L Blanco, Marta E Garcia
Nov 21, 2008·The ISME Journal·George GaitanisJan Faergemann
Mar 12, 2010·Veterinary Microbiology·Sergio Alvarez-PerezMarta E Garcia
Nov 16, 2010·Veterinary Microbiology·Misako NijimaHiroshi Kamata
Jan 1, 2004·Irish Veterinary Journal·Ronan S DoyleChristopher R Bellenger
Oct 4, 2011·Veterinary Microbiology·Claudia CafarchiaDomenico Otranto
Oct 26, 2013·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Caroline Borges WeilerSydney Hartz Alves
Mar 4, 2014·PLoS Pathogens·F Javier Cabañes
Jan 9, 2015·PLoS Pathogens·Aristea VelegrakiTeun Boekhout
Jan 24, 2015·Journal of Speech, Language, and Hearing Research : JSLHR·Jill GilkersonKeith Topping

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.